Other Medical Disorders

Chapter 15


Other Medical Disorders



15.1


Thyroid Disease



The main function of the thyroid gland is to produce the thyroid hormones triiodothyronine and thyroxine, which play a critical role in the regulation of metabolism. Sleep can be affected by three types of thyroid abnormalities: 1) hyperthyroidism, 2) hypothyroidism, and 3) thyroid mass lesions.



Hyperthyroidism


Hyperthyroidism is caused by diseases of the thyroid gland that result in the production of too much thyroid hormone. These include Graves disease, thyroiditis, thyroid nodules, and ingestion of too much iodine or thyroid medication. Less often, in perhaps 1% of cases, hyperthyroidism is caused by a thyroid-stimulating hormone (TSH)–secreting adenoma of the anterior pituitary. In hyperthyroidism, the excessive thyroid hormone results in general symptoms and sleep-related symptoms and findings, which are described in Table 15.1-1, Boxes 15.1-1 and 15.1-2, and Figures 15.1-1 to 15.1-4.










Hypothyroidism


The clinical features of hypothyroidism are those related to a hypometabolic state and those related to the effect on the cardiovascular and respiratory systems; these are described in Boxes 15.1-3 through 15.1-5, and Figures 15.1-5 to 15.1-8. Hypothyroidism is a risk factor for the development of sleep apnea and is much more common in women than in men. In particular, patients who have been diagnosed with Hashimoto thyroiditis are at risk.











Selected Readings



Bozkurt, NC, Karbek, B, Cakal, E, et al. The association between severity of obstructive sleep apnea and prevalence of Hashimoto’s thyroiditis. Endocr J. 2012; 59(11):981–988.


Misiolek, M, Marek, B, Namyslowski, G, et al. Sleep apnea syndrome and snoring in patients with hypothyroidism with relation to overweight. J Physiol Pharmacol. 2007; 58(Suppl 1):77–85.


Neal, JM, Yuhico, RJ. “Myxedema madness” associated with newly diagnosed hypothyroidism and obstructive sleep apnea. J Clin Sleep Med. 2012; 8(6):717–718.


Resta, O, Carratù, P, Carpagnano, GE, et al. Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS). J Endocrinol Invest. 2005; 28(10):893–898.


Resta, O, Pannacciulli, N, Di Gioia, G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis. 2004; 14(5):248–253.



15.2


Diseases of the Pituitary Gland




Anatomy


The pituitary gland is located near several structures that are involved in the regulation of sleep (Fig. 15.2-1). Above the pituitary is the hypothalamus, which contains centers involved in the regulation of sleep and temperature, and the suprachiasmatic nucleus, which is the master controller of the circadian rhythm.



Thus any space-occupying disease that involves the pituitary or nearby structures, such as ademomas and crainiopharyngiomas, can affect sleep and may cause sleepiness, insomnia, and temperature dysregulation. In hormone-secreting tumors, the impact on sleep may be related to the effects of the hormone. The best known of the pituitary diseases that affect sleep are those that result in hypersecretion of growth hormone.



Growth Hormone Hypersecretion



Pathophysiology


Hypersecretion of growth hormone can result in metabolic abnormalities and anatomic changes of skeletal and soft tissue structures that may result in obstructive sleep apnea (OSA). The most common cause of excess secretion of growth hormone is a pituitary tumor (see Fig. 15.2-1). The clinical presentation (Box 15.2-1) is related to the age of the patient, the local effects of the enlarging tumor on the structures in and around the pituitary gland, and the resulting metabolic and anatomic changes. When these result in orofacial changes (Figs. 15.2-2 and 15.2-3), the patient may develop OSA.





image


image


image


image


image


Figure 15.2-3 Acromegaly.
A, This is the same patient as shown in Figure 15.2-2, now in her 60s. A large jaw and nose, frontal bossing, coarse facial features, thick skin, and deep facial creases are apparent. The sleep apnea is believed to be due to the anatomic changes, including the enlarged tongue (B) and the abnormal jaw structure. This patient has severe obstructive sleep apnea and has been on nasal continuous positive airway for several years. C, Examination of the lower jaw and dental structures reveals increased space between the teeth caused by enlargement of the jaw. D, Note the frontal bossing and the healed scar from surgery to treat the pituitary tumor. In some patients, the lower jaw juts forward (prognathism). E, One of the first signs the patient noted was enlargement of her hands.


Approximately 30% to 80% of acromegaly patients have sleep apnea. In about two thirds of the patients with sleep-disordered breathing, the apnea is obstructive, and in one third it is central. Some patients may have a waxing and waning breathing pattern. The finding that many patients do not have obstructive apnea suggests that abnormal control of breathing may be present.


When growth hormone excess occurs while a child is still growing, a marked increase in height is apparent, and the condition is termed gigantism. When the growth hormone hypersecretion occurs after growth has ceased, the condition is called acromegaly.






Selected Readings



Borgers, AJ, Romeijn, N, van Someren, E, et al. Compression of the optic chiasm is associated with permanent shorter sleep duration in patients with pituitary insufficiency. Clin Endocrinol (Oxf). 2011; 75(3):347–353.


Hernández-Gordillo, D, Ortega-Gómez Mdel, R, Galicia-Polo, L, et al. Sleep apnea in patients with acromegaly: frequency, characterization and positive pressure titration. Open Respir Med J. 2012; 6:28–33.


Romeijn, N, Borgers, AJ, Fliers, E, et al. Medical history of optic chiasm compression in patients with pituitary insufficiency affects skin temperature and its relation to sleep. Chronobiol Int. 2012; 29(8):1098–1108.


Sze, L, Schmid, C, Bloch, KE, et al. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol. 2007; 156(3):321–329.


Tolis, G, Angelopoulos, NG, Katounda, E, et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology. 2006; 83(3–4):249–257.


van Haute, FR, Taboada, GF, Corrêa, LL, et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol. 2008; 158(4):459–465.


Vallette, S, Ezzat, S, Chik, C, et al. Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf). 2013; 79(1):79–85.


Watson, NF, Vitiello, MV. Management of obstructive sleep apnea in acromegaly. Sleep Med. 2007; 8(5):539–540.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in NEUROLOGY | Comments Off on Other Medical Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access